A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

NCT03802695 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndromes
Mixed Phenotype Acute Leukemia
Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: OrcaGraft (Orca-Q)

Sponsor

Orca Biosystems, Inc.